Top Markets
#1 Ontology Gas Ontology Gas +46.81%
#2 EXOD EXOD +22.08%
#3 Fake World Assets Fake World Assets +22.08%
#4 ETHGas ETHGas +19.07%
#5 Status Status +17.96%
#6 The Black Bull The Black Bull +16.80%
#7 Geodnet Geodnet +16.47%
#8 Ontology Ontology +11.87%
#9 Derive Derive +10.68%
#10 Gas Gas +9.27%
Coin of the day
Ontology Gas Ontology Gas
Instellingen
Taal
DUTCH
Valuta
USD
Thema
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Rang in aandelen #25523
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Aandeelprijs
$9.81
Laatst gesynchroniseerd: 2025-03-18
Marktkapitalisatie
$48.68M
Verandering (1 dag)
1.55%
Verandering (1 jaar)
0.00%
Land
US
Handel AlloVir, Inc. (ALVR)

Categorie

Healthcare
Omzet van AlloVir, Inc. (ALVR)
Omzet in Jun 2026 TTM: 0.00
Volgens de laatste financiële rapporten van AlloVir, Inc. bedraagt de huidige omzet van het bedrijf (TTM) 0.00. In 2023 behaalde het bedrijf een omzet van 0.00 gelijk aan de omzet in het jaar 2022, die 0.00 bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van AlloVir, Inc. van 2018 tot 2026
Omzet aan het einde van elk jaar
Jaar Omzet Wijzigen
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 -100.00%
2019 $165.00K -85.46%
2018 $1.14M 0.00%
Omzet van vergelijkbare bedrijven of concurrenten
Bedrijf Omzet Omzetverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US